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1G-CSF = granulocyte-colony stimulating factor.
Available online http://breast-cancer-research.com/content/6/4/E14
We read with great interest the article by Retsky and
colleagues in this issue of Breast Cancer Research [1].
They hypothesize that there is induced angiogenesis after
breast cancer surgery in approximately 20% of
premenopausal node-positive patients, which stimulates
division of dormant micrometastatic cells and
synchronizes them into a highly chemosensitive state.
Therefore, adjuvant chemotherapy works particularly well
for that patient category. Breast cancer stem cells in the
thousands of micrometastatic cancer cells have the
capacity to repopulate and metastasize. Granulocyte-
colony stimulating factor (G-CSF) stimulates the
pluripotent stem cell and neutrophil precursors to divide
and increase the production of mature neutrophils, thus
enhancing the function of mature neutrophils, which
ameliorates neutropenia and the associated
complications. These breast cancer stem cells have not
been totally characterized, and may carry antigens almost
identical to those carried by hematopoietic stem cells [2].
We hypothesize that G-CSF use in premenopausal node-
positive breast cancer patients, especially in the era of
induced angiogenesis, may activate and repopulate these
dormant breast cancer stem cells more efficiently as well
as stimulating blood stem cells. Consequently, activated
breast cancer stem cells become chemosensitive to cell
cycle-specific various chemotherapeutic agents.
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